A detailed history of Franklin Resources Inc transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Franklin Resources Inc holds 54,883 shares of AVXL stock, worth $301,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,883
Previous 18,172 202.02%
Holding current value
$301,856
Previous $92,000 151.09%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.39 - $5.02 $124,450 - $184,289
36,711 Added 202.02%
54,883 $231,000
Q1 2024

May 13, 2024

SELL
$4.55 - $6.75 $33,383 - $49,524
-7,337 Reduced 28.76%
18,172 $92,000
Q4 2023

Feb 09, 2024

BUY
$5.04 - $9.95 $58,358 - $115,211
11,579 Added 83.12%
25,509 $237,000
Q3 2023

Nov 13, 2023

SELL
$6.55 - $9.37 $136,050 - $194,624
-20,771 Reduced 59.86%
13,930 $91,000
Q2 2023

Aug 11, 2023

BUY
$7.66 - $9.5 $265,809 - $329,659
34,701 New
34,701 $282,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $429M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.